MILESTONE PHARMACEUTICALS
Live / Applied — Fourth extension granted (statement of use) (as of 10 Oct 2025)
What this means for you
Not registered yet, but its 03 Jul 2019 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88499919
- Mark type
- Stylized text
- Filed
- 03 Jul 2019
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular treatment preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, intranasally administered medications, and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular pharmaceuticals
Owner
- Milestone Pharmaceuticals USA, Inc., Charlotte, NC, US
- Milestone Pharmaceuticals USA, Inc., Charlotte, NC, US
Prosecution history
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2025 — SOU EXTENSION 4 GRANTED
- 10 Oct 2025 — SOU EXTENSION 4 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2025 — SOU EXTENSION 3 GRANTED
- 03 Apr 2025 — SOU EXTENSION 3 FILED
- 03 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2024 — SOU EXTENSION 2 GRANTED
- 02 Oct 2024 — SOU EXTENSION 2 FILED
- 02 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jan 2024 — SOU EXTENSION 1 GRANTED
- 03 Jan 2024 — SOU EXTENSION 1 FILED